The Prevention and Management of Haemolytic Disease of the Newborn

Mollison PL Engelfriet CP Contreras M . Blood Transfusion in Clinical Medicine, 9th edn, Chaps 3, 5, 12. Oxford: Blackwell Scientific Publications, 1993.

Tannirandorn Y Rodeck CH . New approaches in the treatment of haemolytic disease of the fetus. In: Marcela Contreras , ed. Blood Transfusion: the Impact of New Technologies. Baillière's Clinical Haematology Series, Vol 3. London: Baillière, 1990:289–320.

Clarke CA . Preventing rhesus babies: the Liverpool research and follow-up. Arch Dis Child 1989;64:1734–40.

Walker RH Hartrick MB . Non-ABO clinically significant erythrocyte allo-antibodies in Caucasian obstetric patients. Transfusion 1991;31:52S.

Nicolaides KH Warenski JC Rodeck CH . The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus iso-immunization. Am J Obstet Gynec 1985;152:341–4.

Engelfriet CP Ouwehand WH . ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. In: Marcela Contreras , ed. Blood Transfusion: the Impact of New Technologies, Baillière's Clinical Haematology Series, Vol 3. London: Baillière, 1990:321–37.

Urbaniak SJ Greiss MA Crawford RJ Fergusson MJC . Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay. Vox Sang 1984;46:323–9.

Nicolaides KH Rodeck CH Mibashan RS Kemp JR . Have Liley charts outlived their usefulness? Am J Obstet Gynec 1986;155:90–4.

Nicolini U Rodeck CH . A proposed scheme for planning intrauterine transfusion in patient with severe Rhimmunisation. J Obstet Gynec 1988;9:162–3.

Bowman JM . Treatment options for the fetus with alloimmune hemolytic disease. Transfus Med Rev 1990;4:191–207.

De la Cámara C Arrieta R González A Iglesias E Omeñaga F . High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519–20.

Margulies M Voto LS Mathet E Margulies M . High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization. Vox Sang 1991;61:181–9.

Bowman JM Pollock JM . Failures of intravenous Rh immune globulin prophylaxis; an analysis of the reasons for such failures. Transfus Med Rev 1987; 1:101–12.

Bowman JM . Controversies in Rh prophylaxis. In: Garratty G , ed. Haemolytic Disease of the Newborn. Arlington, VA: American Association Blood Banks, 1984:67–85.

Tovey LAD Townley A Stevenson BJ . The Yorkshire antenatal ante-D immunoglobulin trial in primigravidae. Lancet 1983;ii:244–6.

Hussey RM Clarke CA . Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989. BMJ 1991;303:445–6.

Thompson KM Hughes-Jones NC . Production and characterization of monoclonal anti-Rh. In: Marcela Contreras , ed. Blood Transfusion: the Impact of New Technologies. Baillière Clinical Haematology, Series, Vol 3. London: Baillière, 1990:243–53.